Alzheimer's Protein May Be Key to Memory, Study Finds

The protein scientists have spent decades trying to eliminate from Alzheimer's patients' brains turns out to be essential for making memories stick.

Researchers at Flinders University in Australia discovered that tau, a protein that forms deadly tangles in Alzheimer's disease, performs a vital job in healthy brains. It helps organize which neurons will encode experiences into long-term memories.

The study, published in Nature Communications in May 2025, used mice to understand how tau works when it's functioning normally. The team found something surprising: tau isn't needed for learning new things or remembering them shortly after. Instead, it's critical for keeping memories strong over days and weeks.

Without properly functioning tau, the specialized brain cells that should lock in a new experience fail to do their job. The memory becomes fragile and hard to recall, even though it technically still exists in the brain.

This explains a mystery that has puzzled doctors for years. Alzheimer's patients start losing the ability to form new memories before their brains show serious damage from tau tangles or amyloid plaques. If tau's normal job includes organizing memory formation, even small disruptions to that process could explain why memory fails early.

The discovery matters because drug companies have invested heavily in treatments designed to reduce tau throughout the brain. Several therapies are now in late-stage clinical trials. If tau plays an essential role in healthy memory, wiping it out completely could backfire.

Biogen's experimental drug diranersen, which showed promising results in May 2025, works by broadly reducing tau production. The company and others now face a tougher challenge: designing treatments that eliminate the abnormal, disease-causing tau while preserving the normal tau that helps memories form.

The researchers found something else encouraging. When they directly stimulated brain cells in tau-impaired mice, the animals could still access their memories. This suggests tau isn't needed to store memories, just to retrieve them using natural cues like sights and sounds.

The Bright Side

This finding doesn't mean years of Alzheimer's research were wasted. Instead, it gives scientists a clearer target. The problem isn't tau itself but too much of the wrong kind of tau in the wrong places.

The discovery follows a similar pattern in amyloid research, where decades of failed drug trials taught researchers to target specific forms of the protein at specific disease stages. That precision eventually led to the first FDA-approved treatments that slow cognitive decline.

More than 6 million Americans live with Alzheimer's today, a number expected to nearly double by 2050. Understanding tau's dual nature as both helper and villain brings researchers closer to treatments that protect memory instead of accidentally interfering with it.

The path forward requires greater precision, but at least now scientists know what they're aiming for.